Be part of the knowledge.™

CME/CE

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.

3667

LikeLikedUnlike

301-315 of 1026

Optimizing Outcomes in Patients With oHCM: The Emerging Role of Cardiac Myosin Inhibitors
CME/CE Broadcast Replay
Optimizing Outcomes in Patients With oHCM: The Emerging Role of Cardiac Myosin Inhibitors
- Iacopo Olivotto, MD
- Ahmad Masri, MD, MS
- Pablo Garcia-Pavia, MD, PhD
- Fabian Knebel, MD, PhD
- Caroline Coats, MD
0.50 credits
Burden and pathophysiology of APOL1 kidney disease
KDIGO Conversations in Nephrology
Burden and pathophysiology of APOL1 kidney disease
- Kirk Campbell, MD
- Bessie Young, MPH, MD
Diagnosing and Treating IBS: It Begins With One Simple Question
CME/CE Broadcast Replay
Diagnosing and Treating IBS: It Begins With One Simple Question
- Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE
- Kimberly D. Orleck, PA-C
1.00 credits
Women’s Sleep Health – Addressing Gaps in OSA Diagnosis and Treatment Across Life Stages
CME/CE Broadcast Replay
Women’s Sleep Health – Addressing Gaps in OSA Diagnosis and Treatment Across Life Stages
- Alison Kole, MD, MPH, FACCP
- Ghada Bourjeily, MD, FCCP
- Rashmi Nisha Aurora, MD
- Audrey Wells, MD
1.00 credits
Current & Emerging Therapies: Treating & Preventing Hereditary Angioedema Attacks in Children & Adults
CME/CE
Current & Emerging Therapies: Treating & Preventing Hereditary Angioedema Attacks in Children & Adults
- Marc A. Riedl, MD, MS
1.00 credits
Case in Point: Applying PI3K Combinations in Early Recurrent HR+/HER2- mBC
MinuteCE®
Case in Point: Applying PI3K Combinations in Early Recurrent HR+/HER2- mBC
- Komal Jhaveri, MD, FACP
- Kevin Kalinsky MD, MS
0.75 program credits
advertisement
MinuteCE®
From Pathway to Patient: Clinical Advances in PI3K-Directed Therapy for HR+/HER2- mBC
- Komal Jhaveri, MD, FACP
- Kevin Kalinsky MD, MS
0.75 credits 8 episodes
Understanding Endocrine Resistance in HR+/HER2- mBC
MinuteCE®
Understanding Endocrine Resistance in HR+/HER2- mBC
- Kevin Kalinsky MD, MS
0.75 program credits
Double Take: Pivotal Data Evaluating PI3K Inhibitor/Endocrine Therapy Regimens in mBC
MinuteCE®
Double Take: Pivotal Data Evaluating PI3K Inhibitor/Endocrine Therapy Regimens in mBC
- Komal Jhaveri, MD, FACP
- Kevin Kalinsky MD, MS
0.75 program credits
Triple Threat: Key Data on Simultaneous Estrogen, CDK4/6, and PI3K Inhibition in mBC
MinuteCE®
Triple Threat: Key Data on Simultaneous Estrogen, CDK4/6, and PI3K Inhibition in mBC
- Komal Jhaveri, MD, FACP
- Kevin Kalinsky MD, MS
0.75 program credits
PI3K Pathway Inhibitors: Safety and Tolerability Profiles
MinuteCE®
PI3K Pathway Inhibitors: Safety and Tolerability Profiles
- Komal Jhaveri, MD, FACP
- Kevin Kalinsky MD, MS
0.75 program credits
Comprehensive Biomarker Testing in mBC Informs Clinical Decision Making
MinuteCE®
Comprehensive Biomarker Testing in mBC Informs Clinical Decision Making
- Komal Jhaveri, MD, FACP
- Kevin Kalinsky MD, MS
0.75 program credits
advertisement
PI3K Pathway Inhibition in HR+/HER2- mBC: Mechanistic Insights
MinuteCE®
PI3K Pathway Inhibition in HR+/HER2- mBC: Mechanistic Insights
- Komal Jhaveri, MD, FACP
- Kevin Kalinsky MD, MS
0.75 program credits
The Future of PI3K Inhibition in HR+/HER2- Breast Cancer
MinuteCE®
The Future of PI3K Inhibition in HR+/HER2- Breast Cancer
- Komal Jhaveri, MD, FACP
- Kevin Kalinsky MD, MS
0.75 program credits
Behind the Screens: Innovations in Type 1 Diabetes Clinical Trials—From Immunomodulation to Screening Strategies and Advanced Cell Therapies
CME/CE
Behind the Screens: Innovations in Type 1 Diabetes Clinical Trials—From Immunomodulation to Screening Strategies and Advanced Cell Therapies
- Irene Caruso

Program Chapters

Segment Chapters

Playlist:

Recommended